← Back to Clinical Trials
Recruiting NCT07470528

NCT07470528 Comparative Outcomes of Subtunical Microdissection and Grafting Versus Classical Plaque Incision and Grafting in Complex Peyronie's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07470528
Status Recruiting
Phase
Sponsor Namik Kemal University
Condition Peyronie's Disease (PD)
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-05-27
Primary Completion 2026-10

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Subtunical microdissection and graftingClassic plaque Incision and Grafting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-05-27 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical study is to compare two surgical techniques used for the treatment of complex Peyronie's disease. Peyronie's disease can cause penile curvature, deformity, and difficulties during sexual intercourse due to fibrotic plaques within the penile tunica albuginea. In patients with severe deformity, surgical correction is often required. The main question this study aims to answer is whether subtunical microdissection can provide effective correction of penile curvature while preserving erectile function when compared with the classical plaque incision and grafting technique. Participants with complex Peyronie's disease who require surgical correction will undergo either subtunical microdissection or classical plaque incision and grafting. In order to standardize the procedures, the same graft material will be used in both surgical techniques. A bovine pericardial graft will be applied in all cases, and graft size will be determined according to the geometric principles described by Egydio. In the subtunical microdissection technique, the subtunical plane beneath the Peyronie's plaque is carefully dissected using microsurgical instruments under approximately 3.5× optical magnification with surgical loupes. In the classical technique, plaque incision is performed followed by graft reconstruction of the tunical defect. All surgical procedures will be performed by the same surgical team using a standardized operative approach and a uniform anesthesia protocol. Participants will be followed prospectively after surgery to evaluate penile curvature, erectile function, and patient satisfaction. The results of this study may help determine whether subtunical microdissection represents an effective and safe alternative surgical strategy for the treatment of complex Peyronie's disease.

Eligibility Criteria

Inclusion Criteria: * \- Male patients aged 18 years or older * Diagnosis of Peyronie's disease with stable plaque and stable penile curvature for at least 3 months * Presence of complex Peyronie's disease including severe curvature, multiplanar deformity, hinge effect, hourglass deformity, or large plaques causing functional impairment * Patients requiring surgical correction with graft-based reconstruction * Ability to provide informed consent and comply with follow-up evaluations Exclusion Criteria: * Ossified Peyronie's plaques requiring plaque excision * Congenital penile curvature (congenital chordee) * Previous penile prosthesis implantation * Active phase Peyronie's disease with progressive curvature or penile pain * Severe erectile dysfunction not responsive to medical therapy * History of prior penile reconstructive surgery * Significant systemic illness preventing surgical treatment * Inability to complete postoperative follow-up assessments

Frequently Asked Questions

Who can join the NCT07470528 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Peyronie's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07470528 currently recruiting?

Yes, NCT07470528 is actively recruiting participants. Visit ClinicalTrials.gov or contact Namik Kemal University to inquire about joining.

Where is the NCT07470528 trial being conducted?

This trial is being conducted at Tekirdağ, Turkey (Türkiye).

Who is sponsoring the NCT07470528 clinical trial?

NCT07470528 is sponsored by Namik Kemal University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology